206 related articles for article (PubMed ID: 30488021)
1. Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment.
Chang PY; Huang CC; Hung CH; Yu CY; Wu DK; Hwang JI; Liang PC; Wu RH; Tsai WL; Lin YJ; Liu YS; Liang HL; Lee RC; Chen CH
Liver Cancer; 2018 Oct; 7(4):312-322. PubMed ID: 30488021
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment.
Chang PY; Lee RC; Liang PC; Liu YS; Chuang VP; Wu DK; Cheng YF; Huang JI; Tseng HS; Hung CF; Wu RH; Chern MC; Cheng HM; Wu CH; Cheng SM; Chiang CL; Liang HL
Front Oncol; 2023; 13():1186674. PubMed ID: 37427137
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations.
Lencioni R; de Baere T; Burrel M; Caridi JG; Lammer J; Malagari K; Martin RC; O'Grady E; Real MI; Vogl TJ; Watkinson A; Geschwind JF
Cardiovasc Intervent Radiol; 2012 Oct; 35(5):980-5. PubMed ID: 22009576
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T).
Liu YS; Chang PY; Liang PC; Ou MC; Hwang JI; Chen CH
J Hepatocell Carcinoma; 2022; 9():811-821. PubMed ID: 35996398
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review.
Martin R; Geller D; Espat J; Kooby D; Sellars M; Goldstein R; Imagawa D; Scoggins C
Hepatogastroenterology; 2012; 59(113):255-60. PubMed ID: 22251546
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
Nam HC; Jang B; Song MJ
World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
[TBL] [Abstract][Full Text] [Related]
7. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
[TBL] [Abstract][Full Text] [Related]
8. Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.
Schicho A; Hellerbrand C; Krüger K; Beyer LP; Wohlgemuth W; Niessen C; Hohenstein E; Stroszczynski C; Pereira PL; Wiggermann P
J Clin Transl Hepatol; 2016 Dec; 4(4):288-292. PubMed ID: 28097096
[No Abstract] [Full Text] [Related]
9. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
10. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.
Song MJ; Chun HJ; Song DS; Kim HY; Yoo SH; Park CH; Bae SH; Choi JY; Chang UI; Yang JM; Lee HG; Yoon SK
J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.
de Baere T; Arai Y; Lencioni R; Geschwind JF; Rilling W; Salem R; Matsui O; Soulen MC
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):334-43. PubMed ID: 26390875
[TBL] [Abstract][Full Text] [Related]
12. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
Woo HY; Heo J
Clin Mol Hepatol; 2015 Dec; 21(4):344-8. PubMed ID: 26770921
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.
Liu YS; Ou MC; Tsai YS; Lin XZ; Wang CK; Tsai HM; Chuang MT
Korean J Radiol; 2015; 16(1):125-32. PubMed ID: 25598680
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
[TBL] [Abstract][Full Text] [Related]
16. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
Young S; Craig P; Golzarian J
Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.
Spreafico C; Cascella T; Facciorusso A; Sposito C; Rodolfo L; Morosi C; Civelli EM; Vaiani M; Bhoori S; Pellegrinelli A; Marchianò A; Mazzaferro V
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):129-34. PubMed ID: 24870698
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control.
Popovic P; Stabuc B; Jansa R; Garbajs M
Radiol Oncol; 2016 Dec; 50(4):418-426. PubMed ID: 27904450
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
20. Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma.
Razi M; Jianping G; Xu H; Ahmed MJ
J Interv Med; 2021 Feb; 4(1):11-14. PubMed ID: 34805941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
